Glycine Protects H9C2 Cardiomyocytes from High Glucose- and Hypoxia/Reoxygenation-Induced Injury via Inhibiting PKCβ2 Activation and Improving Mitochondrial Quality

Abstract

Background Patients with diabetes are more vulnerable to myocardial ischemia reperfusion injury (IRI), which is involved in PKCβ2 activation and mitochondrial dysfunction. Glycine has been documented as a cytoprotective agent to attenuate diabetes-related abnormalities and reduce myocardial IRI, but the underlying mechanisms are still unclear. We determined whether glycine could attenuate high glucose- (HG-) and hypoxia/reoxygenation- (H/R-) induced injury by inhibiting PKCβ2 activation and improving mitochondrial quality in cultured H9C2 cells. Methods H9C2 cells were either exposed to low glucose (LG) or HG conditions with or without treatment of glycine or CGP53353 (a selective inhibitor of PKCβ2) for 48 h, then subjected to 4 h of hypoxia followed by 2 h of reoxygenation (H/R). Cell viability, lactate dehydrogenase (LDH) release, mitochondrial membrane potential (MMP), superoxide dismutase (SOD) activity, and malondialdehyde (MDA) concentration were detected using corresponding commercial kits. Mitochondrial quality control-related proteins (LC-3II, Mfn-2, and Cyt-C) and PKCβ2 activation were detected by Western blot. Results HG stimulation significantly decreased cell viability and SOD activity and increased LDH release, MDA production, and PKCβ2 activation as compared to LG group, all of which changes were further increased by H/R insult. Glycine or CGP53353 treatment significantly reduced the increase of LDH release, MDA production, PKCβ2 activation, and Cyt-C expression and the decrease of cell viability, SOD activity, MMP, Mfn-2 expression, and LC-3II/LC-3I ratio induced by HG and H/R stimulation. Conclusions Supplementary glycine protects H9C2 cells from HG- and H/R-induced cellular injury by suppressing PKCβ2 activation and improving mitochondria quality.

Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR‐1‐dependent pathway

“…In order to investigate the effects of telmisartan treatment on hypoxic conditions alone, and not in combination with the serum and glucose deprivation (SGD), following the 6-hour hypoxia the medium with CoCl 2 was replaced by DMEM without CoCl 2 for 2-hour reoxygenation. 26,27 Sixty minutes before the hypoxia/reoxygenation, 23 cells were exposed to a dose of telmisartan (50 µmol/L; H/R Tel group) already reported as effective on H9c2 cells, and to its vehicle dimethyl sulfoxide (DMSO 1% in cell medium; H/R DMSO group). 18 At the end of the hypoxia/reoxygenation period, cell morphology was observed with optic microscopy (Leica DMi1, Germany).…”

Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer*

“…The involvement of the metabolites shown at Fig. 1G improving mitochondrial quality and increasing or maintaining mitochondrial activity has been described in different models (29). Importantly, the known Warburg effect in cancer -measured by high glucose consumption and lactate release-provoked by glycolytic stromal fibroblasts, increased mitochondrial activity in adjacent breast cancer cells in vivo (30).…”

Trolox prevents high glucose‐induced apoptosis in rat myocardial H9c2 cells by regulating GLUT‐4 and antioxidant defense mechanism

“…To study the effect of different concentrations of glucose, DMEM media with low glucose is often used although, H9c2 cells were cultured in DMEM media containing 25 mM . DMEM media with 5.5 mM glucose is suggestible as it corresponds to 100 mg/dL and is similar to the normal blood glucose level of human.…”